A comprehensive view of UPM Biomedicals. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Logistic & Supply Chain Market Intelligence Service.
Nanofibrillar cellulose firm UPM Biomedicals signs distribution agreement with Brinter for GrowInk bioinks in multiple countries including the US, Canada, most of Europe; Brinter develops cartilage implants using their patented 3D bioprinting technology
Published:
December 21, 2023
by UPM Kymmene Oyj
|
UPM Biomedicals reports clinical investigation has started for its FibDex nanocellulose wound dressing on superficial burns; FibDex, previously used for skin graft donor sites, is breathable, biocompatible, and promotes efficient wound healing
Published:
June 22, 2023
by UPM Kymmene Oyj
|
Ask us about our Logistic & Supply Chain market view